1Grundmann O, Yoon SL. Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health- care practitioners. J Gastroenterol Hepatol, 2010,25: 691- 699.
2Lee OY. Prevalence and risk factors of irritable bowel syndrome in Asia. J Neurogastroenterol Motil, 2010, 16 : 5- 7.
3Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology, 2006, 130: 1377- 1390.
4Amouretti M, Le Pen C, Gaudin AF, et al. Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroenterol Clin Biol, 2006,30:241-246.
5Faresj0 A, Grodzinsky E, Johansson S,et al. A population- based case-control study of work and psyehosoeial problems in patients with irritable bowel syndrome--women are more seriously affected than men. Am J Gastroenterol, 2007,102 : 371-379.
6Zhao Y, Zou D, Wang R, et al. Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther, 2010,32 : 562-572.
7Sperber AD, Shvartzman P, Friger M, et al. A comparative reappraisal of the Rome II and Rome II1 diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome? Eur J Gastroenterol Hepatol, 2007,19:441-447.
8Cain KC, Jarrett ME, Burr RL, et al. Gender differences in gastrointestinal, psychological, and somatic symptoms in irritable bowel syndrome. Dig Dis Sci, 2009,54:1542-1549.
9Han SH, Lee OY, Bae SC, et al. Prevalence o{ irritable bowel syndrome in Korea~ population-based survey using the Rome II criteria. J Gastroenterol Hepatol, 2006,21:1687- 1692.
10Lee S, Wu J, Ma YL, et al. Irritable bowel syndrome is strongly associated with generalized anxiety disorder., a community study. Aliment Pharmacol Ther, 2009,30 : 643-651.
